We are live on ! Find out more
APVO icon

Aptevo Therapeutics
APVO

0 hedge funds and large institutions have $1.79M invested in Aptevo Therapeutics in 2020 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% less ownership

Funds ownership: 0% → 0% (-0%)

79% less capital invested

Capital invested by funds: $8.62M → $1.79M (-$6.83M)

100% less funds holding

Funds holding: 1 → 0 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
–
Holders Change
-1
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
1
Calls
$2.77M
Puts
–
Net Calls
+$2.77M
Net Calls Change
+$2.28M

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
SCM
Stonepine Capital Management
Oregon
-$2.73M
2
PWAM
Park West Asset Management
California
-$654K
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$354K
4
FM
Fondren Management
Texas
-$79K
5
WG
Winton Group
United Kingdom
-$74K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$670K – – –
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$587K – – –
Vanguard Group
3
Vanguard Group
Pennsylvania
$223K – – –
WVP
4
Worth Venture Partners
New Jersey
$131K – – –
BlackRock
5
BlackRock
New York
$81K – – –
UBS Group
6
UBS Group
Switzerland
$43K – – –
Geode Capital Management
7
Geode Capital Management
Massachusetts
$38K – – –
ACA
8
Atlas Capital Advisors
Wyoming
$8.47K – – –
Victory Capital Management
9
Victory Capital Management
Texas
$4K – – –
Royal Bank of Canada
10
Royal Bank of Canada
Ontario, Canada
$3K – – –
PA
11
Parallel Advisors
California
$2K – – –
Morgan Stanley
12
Morgan Stanley
New York
$1K – – –
PNC Financial Services Group
13
PNC Financial Services Group
Pennsylvania
$1K – – –
TRSOTSOK
14
Teachers Retirement System of the State of Kentucky
Kentucky
$1K – – –
TRCT
15
Tower Research Capital (TRC)
New York
$1K – – –
SCM
16
Stonepine Capital Management
Oregon
– -$2.73M -1 Closed
Acadian Asset Management
17
Acadian Asset Management
Massachusetts
– -$354K – –
AG
18
Algert Global
California
– -$13K – –
Bank of New York Mellon
19
Bank of New York Mellon
New York
– -$37K – –
BFM
20
Boothbay Fund Management
New York
– -$51K – –
California Public Employees Retirement System
21
California Public Employees Retirement System
California
– -$14K – –
CIBC Asset Management
22
CIBC Asset Management
Ontario, Canada
– -$46K – –
CSIC
23
Clifford Swan Investment Counsel
California
– -$18K – –
FM
24
Fondren Management
Texas
– -$79K – –
Northern Trust
25
Northern Trust
Illinois
– -$51K – –
1
2

APVO Hedge Fund Activity: Q1 2020 in Review

0 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Aptevo Therapeutics (APVO) for Q1 2020, worth a combined $1.79M — down 79% from $8.62M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of APVO and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Stonepine Capital Management, exiting entirely with an estimated $2.73M sold.

  • 0 institutional investors held Aptevo Therapeutics (APVO) as of Q1 2020, down from 1 in Q4 2019.
  • Funds reported $1.79M of Aptevo Therapeutics stock for Q1 2020, down 79% quarter-over-quarter.
  • 0 funds opened new Aptevo Therapeutics positions in Q1 2020 and 1 closed out, a net change of -1 holder.
  • The largest Aptevo Therapeutics seller in Q1 2020 was Stonepine Capital Management, an estimated $2.73M sold.

Based on aggregated 13F filings for Q1 2020.